132284-03-8 ([(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基](4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-羟基-3,4-双[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基]氧-2,2,6a,6b,9,12a-七甲基1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢吡啶-4a-羧酸盐,[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-hydroxy-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate)

CAS号:
132284-03-8
中文名称:
[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基](4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-羟基-3,4-双[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基]氧-2,2,6a,6b,9,12a-七甲基1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢吡啶-4a-羧酸盐
英文名称:
[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-hydroxy-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
分子式:
C53H86O22
分子量:
1075.23675966263
植物源:

[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基](4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-羟基-3,4-双[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基]氧-2,2,6a,6b,9,12a-七甲基1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢吡啶-4a-羧酸盐(132284-03-8)名称与标识符

名称

英文别名:
Araliasaponin XII;Guaiacin F;3β-[[2-O,3-O-Di(β-D-glucopyranosyl)-α-L-arabinopyranosyl]oxy]-5α-olean-12-en-28-oic acid β-D-glucopyranosyl ester;[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1;

标识符

InChIKey:
FSZGVSDOMLHPLI-BOMVUIQGSA-N
Inchi:
1S/C53H86O22/c1-48(2)14-16-53(47(67)75-45-40(66)37(63)34(60)28(21-56)71-45)17-15-51(6)23(24(53)18-48)8-9-30-50(5)12-11-31(49(3,4)29(50)10-13-52(30,51)7)72-46-42(74-44-39(65)36(62)33(59)27(20-55)70-44)41(25(57)22-68-46)73-43-38(64)35(61)32(58)26(19-54)69-43/h8,24-46,54-66H,9-22H2,1-7H3/t24-,25-,26+,27+,28+,29-,30+,31-,32+,33+,34+,35-,36-,37-,38+,39+,40+,41-,42+,43-,44-,45-,46-,50-,51+,52+,53-/m0/s1
SMILES:
O([C@H]1[C@@H]([C@H]([C@H](CO1)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@@H](CO)O6)O)O)O)CCC(C)(C)C[C@H]5C4=CC[C@@H]32)C1(C)C

[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基](4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-5-羟基-3,4-双[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)氧-2-基]氧-2,2,6a,6b,9,12a-七甲基1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-十四氢吡啶-4a-羧酸盐(132284-03-8)物化性质

计算特性

  • 氢键供体数量 : 13
  • 氢键受体数量 : 22
  • 可旋转化学键数量 : 12
  • 重原子数量 : 75
  • 复杂度 : 2060
  • 拓扑分子极性表面积 : 354